Podcast

Podcast: This Week in Managed Care—A Plan to Drive Down Drug Prices and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care stories included President Donald Trump's plan to drive down drug prices; the FDA approved the first biosimilar of the year; a study found rapid uptake of PD-1 agents after FDA approval.

iTunes: http://apple.co/2eYWTss

TuneIn: http://bit.ly/2gv7iwj

Stitcher: http://bit.ly/2gCqtFg

Listen above or through one of these podcast services:

Trump Offers Blueprint to Drive Down Prescription Drug Prices; Targets Rebates, "Middlemen"

Azar Stumps for Plan to Hold Down Prescription Drug Costs

FDA Approves Epoetin Alfa Biosimilar for Anemia

Study Finds Rapid Uptake of Anti—PD-1 Agents Following FDA Approval

Researcher Details Microbiome Mysteries Connecting the Gut, Brain

Society of Biological Psychiatry 73rd Annual Scientific Convention

American Thoracic Society 2018 International Conference

ISPOR Annual Conference

Newsletter Signup

Read more about the stories in this podcast:

Related Videos
Kara Kelly, MD, chair of pediatrics, Roswell Park Oishei Children's Cancer and Blood Disorders Program
Sandra Cuellar, PharmD
Wanmei Ou, PhD, vice president of product, data analytics, and AI at Ontada
Glenn Balasky, executive director of the Rocky Mountain Cancer Center.
Corey McEwen, PharmD, MS
dr linda bosserman
dr andrew leitner
Glenn Balasky during a video interview
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo